𝔖 Bobbio Scriptorium

✦ LIBER ✦

Platelet glycoprotein IIb/IIIa receptor inhibition during PTCA for acute MI: a retrospective analysis of in hospital and one year outcome

✍ Scribed by J.A. Grantham; D. Hasdal; S.L. Kopecky; D.R. Holmes

Book ID: 119550406
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 132 KB
Volume: 31
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(98)81641-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of platelet glycoprotein IIb/III

Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction

✍ Jeffrey Lefkovits; Russell J. Ivanhoe; Robert M. Califf; Bruce A. Bergelson; Kea 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 831 KB

THE EFFICACY AND SAFETY OF TICAGRELOR AS

THE EFFICACY AND SAFETY OF TICAGRELOR AS COMPARED TO CLOPIDOGREL, WITH AND WITHOUT A GLYCOPROTEIN IIB/IIIA INHIBITOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS INTERVENTION: A PLATO (STUDY OF PLATELET INHIBITION AND PATIENT OUTCOMES) ANALYSIS

✍ Bansilal, Sameer; Wiviott, Stephen; Becker, Richard; Harrington, Robert; Himmelm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 249 KB

The Efficacy and Safety of Prasugrel Wit

The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON–TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis In Myocardial Infarction 38) Analysis

✍ Michelle O'Donoghue; Elliott M. Antman; Eugene Braunwald; Sabina A. Murphy; P. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 480 KB